Frontlight ResearchEarly access
CompletedPhase 4
Dexamethasone for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery
Key facts
- Who runs it
- Poznan University of Medical Sciences
- Where
- Poland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 60 people enrolled
- Started
- 1 Oct 2024
- Ended
- 7 Oct 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Dexamethasone
- 0.9%NaCl
- Record updated
- 24 November 2025
Who can take part
- Age
- 10 years to 18 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- children scheduled for idiopathic scoliosis surgery
- age >10 and <18 years
Who cannot take part
- steroid medication in regular use
- infection at the site of the regional blockade
- coagulation disorders
- age < 10 years
- age < 18 years
- immunodeficiency
- ASA= or >4
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Effect of perineurial dexamethasone on erector spinal plane block duration for pediatric, idiopathic scoliosis surgery.
The 2 groups in the trial
- DEXAMETHASONEExisting treatment, for comparison
0.2% ropivacaine + 0.1mg/kg Dexamethasone for erector spinae plane block
- CONTROLPlacebo, for comparison
0.2% ropivacaine for erector spinae plane block
Treatment: 0.9%NaCl
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Dexamethasone for ESPB in Pain Management After Pediatric Idiopathic
- Record updated
- 24 November 2025